Related Experiment Video
Updated: Jun 20, 2026
04:36
An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice
Published on: January 12, 2024
[Diabetes and road traffic collisions]
Zygmunt Chodorowski1, Jacek Sein Anand, Adam Hajduk
1Katedra i Klinika Chorób Wewnetrznych, Geriatrii i Toksykologii, Akademii Medycznej w Gdańsku.
Przeglad Lekarski
|October 1, 2009
Summary
Insulin-treated diabetes can cause hypoglycemia, potentially affecting driving safety. However, studies show no significantly higher accident rates compared to the general population, emphasizing individual driving assessments.
Area of Science:
- Endocrinology
- Neurology
- Traffic Safety
Context:
- Insulin-treated diabetes presents risks for drivers, primarily due to hypoglycemia.
- Despite risks, no conclusive evidence links diabetic drivers to increased accident rates.
- Individual patient variability in diabetes necessitates personalized driving qualification.
Purpose:
- To analyze the impact of insulin-treated diabetes on driving safety.
- To evaluate the association between diabetes, hypoglycemia, and road traffic accidents.
- To assess the effectiveness of interventions like Blood Glucose Awareness Training.
Summary:
- Hypoglycemia is the main driving risk for insulin-treated diabetes patients.
- No consistent evidence shows diabetic patients cause more accidents than the general population.
- Individual assessment is crucial for driver's license candidates with diabetes, especially considering complications and self-limitation in elderly drivers.
Impact:
- Blood Glucose Awareness Training can reduce road traffic collisions among diabetic drivers.
- Highlights the need for individualized medical evaluations for driving eligibility.
- Informs public health policy regarding diabetic drivers and road safety measures.
Related Concept Videos
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:22Complications of Diabetes Mellitus
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...